Yong Yu - Sep 13, 2023 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
VP, Clinical Trial Operations
Signature
/s/ Thomas Zindrick, J.D., Attorney-in-Fact
Stock symbol
GNLX
Transactions as of
Sep 13, 2023
Transactions value $
-$629,927
Form type
4
Date filed
9/15/2023, 09:06 PM
Previous filing
Sep 12, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNLX Common Stock Sale -$630K -29.8K -21.92% $21.14 106K Sep 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $21.1385, and the range of prices were between $21.00 and $21.58. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.